Acute cardiac care & resuscitationRandomised controlled trial

Beneficial Effects of Ketone Ester in Patients With Cardiogenic Shock

JACC Heart FailPublished

  • Randomised crossover trial
  • double-blind
  • placebo-controlled

Authors' conclusion

Treatment with KE improved cardiac output, biventricular function, tissue oxygenation, and glycemic control in patients with CS

Study context

Population
Patients with cardiogenic shockcrossover
Participants
12 patients
Comparison
Ketone ester vs placebo
Primary endpoint
Hemodynamic effects (cardiac output)
Follow-up
3 hours after each intervention

Primary result

As reported in the abstract

Cardiac output (AUC of relative change)

P = 0.044

Further findings

Circulating 3-hydroxybutyrate

P < 0.001

Outcomeincrease (W) (95% CI)P value
Cardiac power output, mixed venous saturation, forearm perfusion · cardiac power output0.07 (0.01–0.14)P = 0.037
Outcomeincrease (percentage points) (95% CI)P value
Cardiac power output, mixed venous saturation, forearm perfusion · mixed venous saturation3 (1–5)P = 0.010
Cardiac power output, mixed venous saturation, forearm perfusion · forearm perfusion3 (0–6)P = 0.026

Ventricular filling pressures, HR, mean arterial and pulmonary arterial pressures

Right ventricular filling pressure reduced
P = 0.048
Left ventricular filling pressure reduced
P = 0.017
HR and mean arterial and pulmonary arterial pressures remained similar

LVEF, glucose, insulin

LVEF improved
4 percentage points (95% CI: 2-6 percentage points; P = 0.005)
Glucose decreased
2.6 mmol/L (95% CI: −5.2 to 0.0; P = 0.047)
Insulin levels remained unaltered

Original publication

Beneficial Effects of Ketone Ester in Patients With Cardiogenic Shock. JACC Heart Fail. Published 12 July 2023. doi:10.1016/j.jchf.2023.05.029

Summarised from the published abstract; every number is checked against it